Abstract
Objective: Several studies point to a shine of bidirectional communication between intestinal microbiota and the central nervous system associated with cognitive and neurodegenerative disorders and intestinal symptoms. In this sense, the present study aims to analyze, through an integrative review, the works that evaluate whether there is a relationship between the intestinal microbiota and autism spectrum disorder. Methods: To build a methodology, two databases of medical-scientific content were consulted: PubMed and Lilacs. The search covered articles in English published between 2014 and 2024, focusing on primary articles. A total of 149 articles were found, of which 134 were excluded because they did not fit the proposed theme, resulting in 13 articles for analysis. Results: During the development of the work, it was found that the interaction of the gut-brain axis has a strong influence on the intestinal microbiota of individuals on the autism spectrum, which can lead to an imbalance in this microbiome. Final considerations: An important causal influence of the bidirectional brain-intestine-microbiota axis was found in the etiology and worsening of clinical manifestations of Autism Spectrum Disorder due to intestinal dysbiosis and gastrointestinal factors of idiopathic origin.
References
ALSHAMMARI MK, et al. Incidence of Clostridium perfringens and its toxin genes in the gut of children with autism spectrum disorder. Anaerobe, 2020; 102114.
BARAIBAR, R. Incidence and risk factors of acute otitis media in children. Clinical Microbiology and Infection: The Official Publication of the European Society of Clinical Microbiology and Infectious Diseases, 1997; 3(3): S13–S22.
BOLTE, E. R. Autism and clostridium tetani. Medical Hypotheses, 1998; 21(2): 133–144.
BONAZ B, et. al. The Vagus Nerve at the Interface of the Microbiota-Gut-Brain Axis. Frontiers in Neuroscience, 2018; 12(49).
CARISSIMI C, et al. Functional analysis of gut microbiota and immunoinflammation in children with autism spectrum disorders. Digestive and Liver Disease, 2019; 1(10): 1366–1374.
CHANG X, et al. Gut microbiome and serum amino acid metabolome alterations in autism spectrum disorder. Scientific Reports, 2024; 14(1): 4037.
CORTESE N, et al. The neuro-immune axis in cancer: Relevance of the peripheral nervous system to the disease. Immunology Letters, 2020.
FRANK MG, et al. Could Probiotics Be Used to Mitigate Neuroinflammation? ACS chemical neuroscience, 2018; 10(1): 13–15.
GANAL‐VONARBURG SC e DUERR CU. The interaction of intestinal microbiota and innate lymphoid cells in health and disease throughout life. Immunology, 2019; 159(1): 39–51.
GIAU V, et al. Gut Microbiota and Their Neuroinflammatory Implications in Alzheimer’s Disease. Nutrients, 2018; 10(11): 1765.
GOMES DSA, et al. Alteração da microbiota intestinal e patologias associadas: importância do uso de prebióticos e probióticos no seu equilíbrio, Brasil. Temas em Saúde, 2019.
HUANG Y, et al. Immune-Correlates Analysis of an HIV-1 Vaccine Efficacy Trial Reveals an Association of Nonspecific Interferon-c Secretion with Increased HIV-1 Infection Risk: A Cohort- Based Modeling Study. Plos One, 2014.
JENDRASZAK M, et al. Commercial microbiota test revealed differences in the composition of intestinal microorganisms between children with autism spectrum disorders and neurotypical peers. Scientific Reports, 2021; 11(1).
KIM CS, et al. Probiotic supplementation improves cognitive function and mood with changes in gut microbiota in community-dwelling elderly: A randomized, double-blind, placebo-controlled, multicenter trial. The Journals of Gerontology, 2020; 76(1).
KONG XJ, et al. Probiotic and Oxytocin Combination Therapy in Patients with Autism Spectrum Disorder: A Randomized, Double-Blinded, Placebo-Controlled Pilot Trial. Nutrients, 2021; 13(5): 1552.
LI W, et al. Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Science China Life Sciences, 2017; 60(11): 1223–1233.
MARGOLIS KG, et al. The Microbiota-Gut-Brain Axis: From Motility to Mood. Gastroenterology, 2021; 1486–1501.
MARTINEZ CLD. Microbiota intestinal, disbiose, nutrição e doença de Alzheimer: tem alguma relacao? Dissertação (pós-graduação em neurociências) - Universidade Federal de Minas Gerais, Belo Horizonte, Brasil, 2021.
MCKENNA CF, et al. Higher protein intake during resistance training does not potentiate strength, but modulates gut microbiota, in middle-aged adults: a randomized control trial. American Journal of Physiology-Endocrinology and Metabolism, 2021; 320(5): 900–913.
MEIJER K, et al Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Current Opinion in Clinical Nutrition and Metabolic Care, 2010; 13(6): 715–721.
MEIJER K, et. al. Butyrate and other short-chain fatty acids as modulators of immunity: what relevance for health? Current Opinion in Clinical Nutrition and Metabolic Care, 2010; 13(6): 715–721.
MOREIRA G, et. al. Obesidade, firmicutes e bacteroidetes: uma revisão da literatura. Dissertação - Centro Universitário de Brasília, 2018.
PAIXÃO LA e CASTRO FFS. Colonização da microbiota intestinal e sua influência na saúde do hospedeiro. Dissertação - Centro Universitário de Brasília, 2016.
PARK C, et al. Probiotics for the treatment of depressive symptoms: An anti-inflammatory mechanism? Brain, Behavior, and Immunity, 2018; 73: 115–124.
PENN AH, et al. Breast Milk Protects Against Gastrointestinal Symptoms in Infants at High Risk for Autism During Early Development. Journal of Pediatric Gastroenterology and Nutrition, 2016; 62(2): 317–327.
SANCTUARY MR, et al. Pilot study of probiotic/colostrum supplementation on gut function in children with autism and gastrointestinal symptoms. PLOS ONE, 2019; 14(1): 210064.
SILVA JCL, et al. Microbiota Intestinal e Sistema Nervoso Central: explorando o eixo cérebro e intestino. Revista Neurociências, 2022; 30: 1–29.
SON JS, et al. Comparison of Fecal Microbiota in Children with Autism Spectrum Disorders and Neurotypical Siblings in the Simons Simplex Collection. PLOS ONE, 2015; 10(10): 137725.
SOUZA L. Clostridium perfringens: Uma revisão. Dissertação (pós-graduação) - Universidade federal de minas gerais (ufmg), instituto de ciências biológicas -icb departamento de microbiologia, Belo Horizonte-Brasil, 2017.
TOMOVA A, et al. Gastrointestinal microbiota in children with autism in Slovakia. Physiology & Behavior, 2015; 138: 179–187.
VAGAS ACCO, et al. Aspectos alimentares atuais e alteração da microbiota intestinal em indivíduos com obesidade/ Current dietary aspects and altered gut microbiota in obese individuals. Brazilian Journal of Health Review, 2021; 4(2): 5336–5352.
WAN Y, et al. Alterations in fecal virome and bacteriome virome interplay in children with autism spectrum disorder. Cell Reports. Medicine, 2024; 5(2): 101409.
WANG M, et al. Alteration of gut microbiota-associated epitopes in children with autism spectrum disorders. Brain, Behavior, and Immunity, 2019; 75: 192–199.
XIE X, et al. Alteration of the fecal microbiota in Chinese children with autism spectrum disorder. Autism Research, 2022.
YU Y, et al. Microbiota-gut-brain axis in autism spectrum disorder. Journal of Genetics and Genomics, 2021; 48(9): 755–762.
ZHANG L, et al. The role of probiotics in children with autism spectrum disorders: A study protocol for a randomised controlled trial. PloS One, 2022; 17(2): 263109.
ZWAIGENBAUM L, et al. Early Identification of Autism Spectrum Disorder: Recommendations for Practice and Research. PEDIATRICS, 2015; 136: S10–S40.
